EUVIMEDEUVIMED entdecken
Open Access

Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates

E Misas iD, E Seagle, E N Jenkins, M Rajeev, S Hurst, N S Nunnally, M L Bentz, M M Lyman, E Berkow, L H Harrison, W Schaffner, T M Markus und 5 weitere

Journal of Clinical Microbiology · 14.02.2024 · 62 (2)

DOI: 10.1128/jcm.01140-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 14.02.2024. Verfasst von E Misas und 16 weiteren Autor:innen. Beteiligte Einrichtung: Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Echinocandins, Candidemia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: ORAU/ORISE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In our study, mutations associated to azole resistance and echinocandin resistance were detected in Candida glabrata isolates using a whole-genome sequence. C. glabrata is the second most common cause of candidemia in the United States, which rapidly acquires resistance to antifungals, in vitro and in vivo .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EchinocandinsCandidemiaHumansFluconazoleCandida glabrataRetrospective StudiesPhylogenyMicrobial Sensitivity TestsAntifungal AgentsMutationGenomicsDrug Resistance, Fungal

Stichwörter der Autor:innen

Candida glabrataWGSantifungalepidemiologygenomicresistance

Substanzen

EchinocandinsFluconazoleAntifungal Agents

Autor:innen und Institutionen

  • Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
  • ASRT, Inc. , Atlanta, Georgia, USA.
  • Department of International Health, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland, USA.
  • Vanderbilt University Medical Center , Nashville, Tennessee, USA.
  • Oregon Public Health Division, Oregon Health Authority , Portland, USA.
  • Emory University School of Medicine , Decatur, Georgia, USA.

ORCID-Profile: E Misas, S R Lockhart, A P Litvintseva

Förderung

  • ORAU/ORISE

Zitieren

APA

Misas, E., Seagle, E., Jenkins, E. N., Rajeev, M., Hurst, S., Nunnally, N. S., Bentz, M. L., Lyman, M. M., Berkow, E., Harrison, L. H., Schaffner, W., Markus, T. M., Pierce, R., Farley, M. M., Chow, N. A., Lockhart, S. R., & Litvintseva, A. P. (2024). Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates. Journal of Clinical Microbiology, 62(2). https://doi.org/10.1128/jcm.01140-23

Vancouver

Misas E, Seagle E, Jenkins EN, Rajeev M, Hurst S, Nunnally NS, et al. Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates. Journal of Clinical Microbiology. 2024;62(2). doi:10.1128/jcm.01140-23

BibTeX
@article{Misas2024,
  author = {Misas, E and Seagle, E and Jenkins, E N and Rajeev, M and Hurst, S and Nunnally, N S and Bentz, M L and Lyman, M M and Berkow, E and Harrison, L H and Schaffner, W and Markus, T M and Pierce, R and Farley, M M and Chow, N A and Lockhart, S R and Litvintseva, A P},
  title = {Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  volume = {62},
  number = {2},
  doi = {10.1128/jcm.01140-23}
}
Kostenlos starten →